Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance.
Waystar became a public company on June 7, 2024.
Waystar stock is traded on the Nasdaq Global Select Market under the ticker symbol "WAY."
Waystar's corporate headquarters are co-located in Lehi, Utah and Louisville, Kentucky.
Waystar was formed in 2017 through the merger of Navicure and ZirMed and is incorporated in Delaware.
Waystar's transfer agent is Broadridge Corporate Issuer Solutions, LLC.
Mailing Address:
Broadridge Shareholder Services
c/o Broadridge Corporate Issuer Solutions
PO Box 1342
Brentwood, NY 11717
Overnight Address:
Broadridge Shareholder Services
c/o Broadridge Corporate Issuer Solutions
Attn: BCIS IWS
51 Mercedes Way
Edgewood, NY 11717
Shareholder Services Toll-Free Number: 844-998-0339
Shareholder Services International Number: 303-562-9304
Waystar's common stock can be purchased on the open market through any registered broker.
Waystar currently does not pay a dividend.
The Waystar fiscal year runs on a calendar year with quarters ending on March 31, June 30, September 30 and December 31.
Waystar's independent accountant is KPMG LLP.
Please view a full list of Waystar's Board of Directors here.
Investors can sign up to receive email alerts here.
Send an email message to investors@waystar.com or call 646-277-1219